Zara Baloch, Director of Quantitative Research and Meta Analysis, Digital Education Manager and Host at MedNews Week, Observer at HCA Houston Healthcare, shared a post on LinkedIn:
“Cellular therapy is advancing rapidly. The more important question is how we translate that progress into better, more accessible care.
Reporting for MedNews Week from the ICE-T Conference in Orlando, I had the opportunity to speak with experts shaping the future of CAR T-cell therapy, bispecific antibodies, and immune effector cell therapy.
It was a valuable learning experience, and I look forward to sharing these conversations and the insights I gained with the broader medical community.
MedNews Week × ICE-T Conference.”
Proceed to the video attached to the post.
Other posts featuring Zara Baloch on OncoDaily.